Velocity-Loss Training and Parkinson's Disease
Comparison of Neuromuscular and Functional Adaptations to 10% and 30% Velocity-Loss Threshold Resistance Training in Persons With Parkinson's Disease
1 other identifier
interventional
60
1 country
1
Brief Summary
This study will compare the effects of velocity-loss resistance training at 10% and 30% velocity loss thresholds on measures of muscle strength and power and tests of daily performance in older adults with Parkinson's disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 18, 2026
CompletedFirst Posted
Study publicly available on registry
September 25, 2026
CompletedStudy Start
First participant enrolled
September 25, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2026
September 28, 2026
September 1, 2026
3 months
September 18, 2026
September 25, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Change in neuromuscular performance as measured by 1-repetition maximum (1RM)
Maximal load that can be lifted in one repetition (1RM) will be assessed in both leg press and chest press exercises. The loads on the testing equipment will be increased across 5 to 7 testing repetitions. The persons 1RM will be the highest load the person can move through the range of motion of the exercise. There are no minimum or maximum scores for this test. The higher the 1RM the stronger the person is. The unit of measurement is kilograms.
Baseline, 12 weeks
Change in neuromuscular performance as measured by Watts
This test measures the power a person can produce at maximal speed using loads of 20%, 40%, 60%, 80%, and 90% of 1RM for the chest press and leg press. Power shows how fast a person can do work. There are no minimum or maximum possible values. Higher values indicate better neuromuscular performance. Unit of measure is Watts.
Baseline, 12 weeks
Secondary Outcomes (6)
Change in the Speed of the Ten-Meter Walk Test.
Baseline, 12 weeks
Change in Time for the Five Times Sit-to-Stand Test.
Baseline, 12 weeks
Change in the time required to complete the timed Up-and-Go Test.
Baseline, 12 weeks
Change in Distance of the Seated Medicine Ball Throw.
Baseline, 12 weeks
Change in Muscle Thickness using Ultrasound.
Baseline, 12 weeks
- +1 more secondary outcomes
Study Arms (2)
10% Velocity-Loss Threshold Resistance Training
ACTIVE COMPARATORParticipants will receive velocity-based resistance training at 10% velocity-loss threshold, twice per week for at least 24 sessions for up to 12 weeks.
30% Velocity-Loss Threshold Resistance Training
EXPERIMENTALParticipants will receive velocity-based resistance training at 30% velocity-loss threshold, twice per week for at least 24 sessions for up to 12 weeks.
Interventions
Participants will receive a total of twenty-four 45-minutes in-person training sessions at 10% velocity-loss threshold, twice per week using three sets of eight repetitions per set. During training participants will be allowed 1-minute rests between sets. Exercises will include four upper-body exercises and 2 lower-body exercises.
Participants will receive a total of twenty-four 45-minutes in-person training sessions at 30% velocity-loss threshold, twice per week using three sets of eight repetitions per set. During training participants will be allowed 1-minute rests between sets. Exercises will include four upper-body exercises and 2 lower-body exercises.
Eligibility Criteria
You may qualify if:
- Parkinson's Disease Hoehn \& Yahr Stages 1-3
- Able to walk 50 meters unassisted
- Able to understand and communicate in English
You may not qualify if:
- Uncontrolled cardiovascular or other neuromuscular disease that prevent participation in a training program
- Any systemic inflammatory or autoimmune conditions such as rheumatoid arthritis, or other serious concomitant medical illness
- Unresolved injury or surgery to the upper or lower limbs that prevents weight training.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Laboratory of Neruomuscular Research and Active Aging
Coral Gables, Florida, 33147, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joseph F. Signorile, PhD
University of Miami - Coral Gables Campus
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 18, 2026
First Posted
September 25, 2026
Study Start
September 25, 2026
Primary Completion (Estimated)
December 30, 2026
Study Completion (Estimated)
December 30, 2026
Last Updated
September 28, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share